Delivery Order SPE2DB20D1109-SPE2DB22FQ05A
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,380.72, is for the delivery of Azelastine 0.1% (137 MCG) Spry 30ML, a pharmaceutical product. This is a delivery order contract with a firm fixed price pricing type. The contract has an ultimate completion date of January 19, 2024. Amerisourcebergen Drug Corp is a subsidiary of Cencora,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $1,392.00 firm fixed price contract is for the supply of 4565433298 - Azelastine 0.1% (137 MCG) Spray, 30ML. It is not a set-aside contract. The delivery order is part of a larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to...
- This contract award (SPE2DB20D2104|SPE2DB22FS22R) is for the delivery of Azelastine 0.1% (137 MCG) nasal spray, a pharmaceutical product, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,005.24 and a performance period ending on March 29, 2022. The contract was not set aside for any specific business...
- The federal contract award SPE2DB20D1100|SPE2DB25FB4X5 was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,473.26 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) for the supply of 4567772462 - AZELASTINE HCL 0.05% DROPS 6ML. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency awarded a $87 firm fixed price delivery order to Amerisourcebergen Drug Corporation for azelastine hydrochloride nasal spray. As the prime contractor, Amerisourcebergen will supply 4561911878 units of the 0.1% 137 mcg spray to the DLA under a one-day period of performance ending August 24, 2023. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will perform the contract from its facilities in Conshohocken, Pennsylvania. The delivery order was issued...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,169 to Amerisourcebergen Drug Corporation for azelastine hydrochloride nasal spray. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the pharmaceutical to its place of performance in Conshohocken, Pennsylvania by September 13, 2023 to fulfill the agency's requirements. No additional details were provided regarding the original solicitation, major subcontractors, or high-level...
- The Defense Logistics Agency awarded a $261 delivery order to Amerisourcebergen Drug Corporation for azelastine hydrochloride nasal spray. As the prime contractor, Amerisourcebergen will supply approximately 137 micrograms of the nasal spray packaged in 30ml bottles to fulfill DLA requirements. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one-day period from August 29 to 30, 2023. The firm fixed price contract was awarded utilizing...
- The Defense Logistics Agency awarded a $72,600 firm fixed price delivery order to Amerisourcebergen Drug Corporation for azelastine hydrochloride nasal spray. As the prime contractor, Amerisourcebergen will supply approximately 137 milligrams of the nasal spray to meet Defense Logistics Agency requirements under the delivery order. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a three-day period in early August 2023. No subcontractors or set aside...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at seventy-two thousand six hundred dollars to Amerisourcebergen Drug Corporation for azelastine hydrochloride nasal spray. As the prime contractor, Amerisourcebergen will supply one hundred thirty-seven milligrams of azelastine nasal spray in thirty milliliter bottles to support the Department of Defense's medical readiness programs. Performance will occur at Amerisourcebergen's facility in Conshohocken,...
- <p>The Defense Logistics Agency issued a $1,180.80 delivery order to Amerisourcebergen Drug Corp on April 17, 2026, for azelastine 0.1% (137 mcg) spray 30 ml.</p> <p>The order is issued under the DLA Troop Support Medical indefinite delivery contract supporting pharmaceutical supply to military healthcare systems. Place of performance is Conshohocken, Pennsylvania. The order has a firm fixed price structure with an ultimate completion date of April 20, 2026.</p>
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB22FQ05ADelivery Order
This federal contract award, with an ID of SPE2DB20D1109|SPE2DB22FQ05A, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,237.04 delivery order contract is for the supply of Azelastine 0.1% (137 MCG) Spray, a pharmaceutical product, with a completion date of September 12, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also does business as Amerisourcebergen. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 9/9/22 |